Search

everythinglearnresearchcommunity

for

Search:↓

Compounds from certain trees used by First Nations people show potential for treating skin conditions and promoting hair growth, but more research is needed to confirm their safety and effectiveness.

Blocking a protein called prostaglandin D2 might help treat hair loss.

New treatments targeting androgen receptors show promise for drug-resistant prostate cancer.

A man with vitiligo and alopecia saw quick skin and hair improvement with ruxolitinib, but skin color gains were lost after stopping treatment.

The WNT signaling pathway is important in many diseases and targeting it could offer new treatments.

New butyric acid prodrugs show promise for cancer treatment, anemia management, and protecting hair from chemotherapy damage.

A blood pressure drug, diltiazem, may also help treat influenza.

A patient with lupus and long-term hair loss saw significant hair regrowth after using the drug tofacitinib.

Trodelvy™ helped some patients with advanced breast cancer, but had side effects.

Existing drugs, including a blood pressure medication, show promise as new treatments for influenza.

2007 research improved understanding of prostate cancer risk, diagnosis, and treatment, but also showed the need for personalized treatment and further study on certain therapies' risks.

In 2007, prostate cancer research improved understanding of risk, diagnosis, and treatment, but also showed heart risks with certain therapies and the need for personalized care.

New treatments for Hepatitis C show promise but need more research to confirm their safety and effectiveness for clinical use.

Blocking the prolactin receptor might help treat various diseases, but more research is needed.

There are several promising treatments for hair loss, including dutasteride, latanoprost, ketoconazole shampoo, anti-androgens, laser/light treatment, and platelet-rich plasma, but more research is needed.

The treatment combination is effective and generally safe for lung cancer.

MK-0773 safely increased muscle mass but did not improve muscle strength or function in elderly women with sarcopenia.

Dutasteride more effective than finasteride for hair growth; SM04554 safe and potentially effective for hair loss.

Safusidenib erbumine shows promise as a treatment for certain brain tumors, but mild side effects like hair loss need attention.

CTP-543 significantly improved eyebrow and eyelash regrowth and patient satisfaction in adults with alopecia areata.

PRP and microneedling both effectively improve hair growth and thickness for treating hair loss.

Topical finasteride is an effective and safer treatment for male hair loss.

Deuruxolitinib effectively promotes hair regrowth in adults with alopecia areata.

Oxymetazoline cream 1.0% effectively reduces rosacea redness, and using baseline photos improves assessment accuracy.

Deuruxolitinib significantly helps regrow scalp hair in adults with moderate to severe alopecia areata.

Baricitinib improved severe hair loss in adults over 52 weeks and was safe to use.

Continued ritlecitinib treatment helps sustain hair regrowth in alopecia areata patients.

DHEA therapy improved pubic hair growth and psychological well-being in young females with adrenal insufficiency.

Hair regrowth from severe alopecia areata treatment with baricitinib can vary, with faster results in those with shorter hair loss duration.

IVL3001 is safe, effective, and better than oral finasteride for treating hair loss.